Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05057676
Other study ID # 202103542
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2021
Est. completion date December 1, 2026

Study information

Verified date July 2023
Source University of Iowa
Contact Study Coordinator
Phone 3193845002
Email MSDietStudy@healthcare.uiowa.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, and post acute sequela of covid


Description:

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, and post acute sequela of covid. Once eligibility criteria are determined and consent is obtained, participants would work through the course modules like a non-graded online course. There are exercises and personal assessments within the course participants are asked to take to build upon each other to increase the success of the experience while taking the course. Throughout the course there will be modules that will discuss an inner game plan, food intervention plan, physical intervention plan, and an increased resilience plan. The fourth module suggests different strategies that participants can do to improve their health beyond food and exercise. These types of things would include supplements, light therapy, detoxification, improved sleep, stress reduction, and other ways to enhance their body's resilience. Investigators ask that participants inform and work with their healthcare team to personalize their treatment and determine if the suggested strategies mentioned in the course are appropriate for their healthcare path. This will provide dietary education to a larger sample size compared to what has been studied in the past. The study may include more patients that have limited resources, including but not limited to, money and location for access to registered dietitians with expertise in dietary instruction for patient s diagnosed with multiple sclerosis and CIS. There is interest in education and support that can be delivered via an online platform that can lead to improved diet quality and self-care routines for multiple sclerosis and autoimmune patients. This study will use a randomized single-blind wait list control design to evaluate the impact of an online course that teaches the modified Paleolithic diet, nutrient dense vegetarian diet and Mediterranean diets, stress reduction and exercise strategies using commercially available online course for autoimmune patients. Data will be collected in the short-term (after 3 months) and long-term (at the end of 6 months ) to analyze the impact of an online wellness program QoL and related outcomes among people with CIS and MS. The study will use a 7-day window to collect baseline assessments. Participants will use a personal email that does not contain identifying information to participate in the study. Participants will be asked to complete all baseline assessments. This email and password will be used for access to the online course materials. Patients will be randomized to the intervention arm based upon the baseline modified fatigue impact score. Patients will receive access to the online program and 7 group support videos (released one per week or 7 weeks total). Participants will access the course materials using the study assigned email. The proposed study will consist of virtual-only participants and will have 3 virtual visits every 3 months (months 0, 3, and 6). Online questionnaires will be sent to the participants to assess fatigue and quality of life. Dietary assessments will include a questionnaire through a web-based tool after baseline, at month 3, and month 6.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date December 1, 2026
Est. primary completion date December 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - self-reported multiple sclerosis - self-reported clinically isolated syndrome OR self-reported post-acute sequelae of COVID (PASC), also known as long COVID, with a confirmed laboratory test of COVID-19 infection, persisting fatigue and neuropsychiatric symptoms for longer than 6 months after confirmation of COVID diagnosis, OR self-reported diagnosis of fibromyalgia as documented by their treating specialist or primary care provider, Exclusion Criteria: -

Study Design


Intervention

Behavioral:
Immediate Autoimmune Intervention Mastery Course (AIM)
Immediate access to an on line audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care
Immediate Question and Answer sessions. (AIM Q and A sessions)
Immediate access to videos answering common questions about the course concepts. One video released each week, 7 videos total.
Delayed Autoimmune Intervention Mastery Course (delayed AIM course)
Delayed access to an on line audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care
Delayed AIM Question and Answer sessions
Delayed access to videos answering common questions about the course concepts. One video released each week, 7 videos total.

Locations

Country Name City State
United States Univeristy of Iowa Iowa City Iowa

Sponsors (1)

Lead Sponsor Collaborator
Terry L. Wahls

Country where clinical trial is conducted

United States, 

References & Publications (9)

Bisht B, Darling WG, Grossmann RE, Shivapour ET, Lutgendorf SK, Snetselaar LG, Hall MJ, Zimmerman MB, Wahls TL. A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue. J Altern Complement Med. 2014 May;20(5):347-55. doi: 10.1089/acm.2013.0188. Epub 2014 Jan 29. — View Citation

Bisht B, Darling WG, White EC, White KA, Shivapour ET, Zimmerman MB, Wahls TL. Effects of a multimodal intervention on gait and balance of subjects with progressive multiple sclerosis: a prospective longitudinal pilot study. Degener Neurol Neuromuscul Dis. 2017 Jun 26;7:79-93. doi: 10.2147/DNND.S128872. eCollection 2017. — View Citation

Chenard CA, Rubenstein LM, Snetselaar LG, Wahls TL. Nutrient Composition Comparison between a Modified Paleolithic Diet for Multiple Sclerosis and the Recommended Healthy U.S.-Style Eating Pattern. Nutrients. 2019 Mar 1;11(3):537. doi: 10.3390/nu11030537. — View Citation

Irish AK, Erickson CM, Wahls TL, Snetselaar LG, Darling WG. Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study. Degener Neurol Neuromuscul Dis. 2017 Jan 4;7:1-18. doi: 10.2147/DNND.S116949. eCollection 2017. — View Citation

Lee JE, Titcomb TJ, Bisht B, Rubenstein LM, Louison R, Wahls TL. A Modified MCT-Based Ketogenic Diet Increases Plasma beta-Hydroxybutyrate but Has Less Effect on Fatigue and Quality of Life in People with Multiple Sclerosis Compared to a Modified Paleolithic Diet: A Waitlist-Controlled, Randomized Pilot Study. J Am Coll Nutr. 2021 Jan;40(1):13-25. doi: 10.1080/07315724.2020.1734988. Epub 2020 Mar 26. — View Citation

Titcomb TJ, Bisht B, Moore DD 3rd, Chhonker YS, Murry DJ, Snetselaar LG, Wahls TL. Eating Pattern and Nutritional Risks among People with Multiple Sclerosis Following a Modified Paleolithic Diet. Nutrients. 2020 Jun 20;12(6):1844. doi: 10.3390/nu12061844. — View Citation

Wahls T, Scott MO, Alshare Z, Rubenstein L, Darling W, Carr L, Smith K, Chenard CA, LaRocca N, Snetselaar L. Dietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trial. Trials. 2018 Jun 4;19(1):309. doi: 10.1186/s13063-018-2680-x. — View Citation

Wahls TL, Chenard CA, Snetselaar LG. Review of Two Popular Eating Plans within the Multiple Sclerosis Community: Low Saturated Fat and Modified Paleolithic. Nutrients. 2019 Feb 7;11(2):352. doi: 10.3390/nu11020352. — View Citation

Wahls TL, Titcomb TJ, Bisht B, Eyck PT, Rubenstein LM, Carr LJ, Darling WG, Hoth KF, Kamholz J, Snetselaar LG. Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: The WAVES randomized parallel-arm clinical trial. Mult Scler J Exp Transl Clin. 2021 Jul 31;7(3):20552173211035399. doi: 10.1177/20552173211035399. eCollection 2021 Jul-Sep. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Multiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH) Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better. baseline to 3 months
Primary Multiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH) Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better. baseline to 6months
Primary Multiple Sclerosis 54 Quality of Life Physical Health (MS 54 QoL PH) Change in (MS 54 QoL PH) survey questions mean scores, range 0-100, higher number is better. baseline to 3 months
Primary Multiple Sclerosis 54 Quality of Life Physical Health (MS 54 QoL PH) Change in (MS 54 QoL PH) survey questions mean scores, range 0-100, higher number is better. baseline to 6 months
Primary Short form 36 (SF 36) Change in (SF 36) survey questions mean scores, range 0-100, higher number is better. baseline to 3 months
Primary Short form 36 (SF 36) Change in (SF 36) survey questions mean scores, range 0-100, higher number is better. baseline to 6 months
Secondary Modified Fatigue Impact Scale Change in MFIS survey questions, scores range from 0-84, lower score is better. baseline to 3 months
Secondary Modified Fatigue Impact Scale Change in MFIS survey questions, scores range from 0-84, lower score is better. baseline to 6 months
Secondary vegetable and fruit intake Change in number of servings of vegetables consumed per day, servings range from 0 to 9 or more baseline to 3 months
Secondary vegetable and fruit intake Change in number of servings of vegetables consumed per day, servings range from 0 to 9 or more baseline to 6 months
Secondary added sugar intake change in the grams of added sugar consumed each day, grams range from 0 to 100 baseline to 3 months
Secondary added sugar intake change in the grams of added sugar consumed each day, grams range from 0 to 100 baseline to 6 months
Secondary calcium intake change in calcium intake, range 0 to 2000 mg baseline to 3 months
Secondary calcium intake change in calcium intake, range 0 to 2000 mg baseline to 6 months
Secondary Servings of whole grains consumed change in number of servings of whole grains consumed, range 0 to 6 or more servings baseline to 3 months
Secondary Servings of whole grains consumed change in number of servings of whole grains consumed, range 0 to 6 or more servings baseline to 6 months
Secondary Fibromyalgia Impact Questionnaire Revised Pain Rating (0-10 Low to High Scale) with higher score indicating greater impact baseline to 3 months
Secondary Fibromyalgia Impact Questionnaire Revised Pain Rating (0-10 Low to High Scale)15 items with higher score indicating greater impact baseline to 6 months
Secondary Brief Pain Inventory Interference (0-10 Low to High Scale) 15 items with higher score indicating greater intensity baseline to 3 months
Secondary Brief Pain Inventory Range 0-10( Low to High Scale) with higher score indicating greater pain intensity baseline to 6 months
Secondary FM Disease activity (FIQR) 0-100( Low to High Scale)21 items used to evaluate function, overall impact, and symptoms in patients with fibromyalgia. baseline to 3 months
Secondary FM Disease activity (FIQR) 0-100 (Low to High Scale)21 items used to evaluate function, overall impact, and symptoms in patients with fibromyalgia. High score indicating more severe symptoms. baseline to 6 months
Secondary Pain scale 0-10 (low to high) 13 items used to evaluate feelings about pain. baseline to 3 months
Secondary Pain catastrophizing scale 052 (low to high) 13 items used to evaluate feelings about pain. Higher scores indicating more severe feelings about pain related problems baseline to 6 months
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4